83 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Tvardi Therapeutics Funding History

Since Tvardi Therapeutics was founded in 2004, it has participated in 10 rounds of funding. In total Tvardi Therapeutics has raised $587.3M. Tvardi Therapeutics' last funding round was on Nov 2023 for a total of $17.5M.

Tvardi Therapeutics Funding Rounds

Unlock 7 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Post-IPO Equity
Nov 2023
$17.5M
1
HealthCare Royalty
Post-IPO Equity
Jul 2019
$145M
__
Post-IPO Equity
Jul 2018
$98.3M
__
Post-IPO Equity
Mar 2017
$92.1M
__
Post-IPO Equity
Aug 2015
$80.5M
__

Total Funding: $587.3M

Tvardi Therapeutics Investors

Unlock 5 more investors →

INVESTOR

ROUND

FUNDING DATE

HealthCare Royalty
Post-IPO Equity
Nov 2023
Rho Ventures
Series D
Jul 2010
Alta Biopharma
Series D
Jul 2010
Ascent Biomedical Ventures
Series D, Series C
Jul 2010, Nov 2006
Connecticut Innovations
Series D
Jul 2010

Total Investors: 8

Tvardi Therapeutics has 8 investors, including HealthCare Royalty, Rho Ventures and Alta Biopharma. The latest investment occurred in Nov 2023.